Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) Asset Utilization Ratio: 2011-2025

Historic Asset Utilization Ratio for Lifecore Biomedical (LFCR) over the last 13 years, with May 2025 value amounting to 0.54.

  • Lifecore Biomedical's Asset Utilization Ratio rose 5.35% to 0.54 in Q2 2025 from the same period last year, while for May 2025 it was 0.54, marking a year-over-year increase of 5.35%. This contributed to the annual value of 0.52 for FY2025, which is 3.37% up from last year.
  • Per Lifecore Biomedical's latest filing, its Asset Utilization Ratio stood at 0.54 for Q2 2025, which was up 2.22% from 0.53 recorded in Q1 2025.
  • Over the past 5 years, Lifecore Biomedical's Asset Utilization Ratio peaked at 0.54 during Q2 2025, and registered a low of 0.24 during Q2 2021.
  • Its 3-year average for Asset Utilization Ratio is 0.48, with a median of 0.50 in 2024.
  • Per our database at Business Quant, Lifecore Biomedical's Asset Utilization Ratio crashed by 83.12% in 2021 and then spiked by 65.85% in 2022.
  • Lifecore Biomedical's Asset Utilization Ratio (Quarterly) stood at 0.28 in 2021, then surged by 44.16% to 0.40 in 2022, then climbed by 13.83% to 0.46 in 2023, then climbed by 13.97% to 0.52 in 2024, then rose by 5.35% to 0.54 in 2025.
  • Its last three reported values are 0.54 in Q2 2025, 0.53 for Q1 2025, and 0.52 during Q4 2024.